The U.S. Food and Drug Administration (FDA) has released a new fast track designation for IDE161, an inhibitor of poly (ADP-ribose) glycohydrolase (PARG) to treat adult patients with advanced or […]
This author has not written his bio yet.
But we are proud to say that MBCA contributed 51 entries already.
Entries by MBCA
Researchers at City of Hope are testing a new type of cancer treatment drug. When tested in animals and cells taken from human cancers, this new drug prevented the growth […]
A breast cancer diagnosis and treatment can affect relationships with romantic partners. This review highlights two studies that looked at how people with breast cancer and their partners are affected, […]
Learn more about lobular breast cancer and what BCRF is doing to accelerate lifesaving research Invasive lobular carcinoma, also referred to as invasive lobular breast cancer (ILC) or simply lobular […]
The U.S. Supreme Court ruled in 2022 that abortion is no longer a protected right under the Constitution. This landmark decision leaves regulation of abortion to the states. Cancer treatment […]